Image by alisbalb2/DepositPhotos
Monsanto has announced a nationwide proposed class settlement to resolve Roundup claims alleging non-Hodgkin lymphoma injuries. The proposed settlement is the second since their initial proposed settlement in 2020 and would include the element of a long-term compensation program providing funding for up to 21 years addressing both current and future claimants.
According to Bayer, “the long-term payment stream will provide the company with both greater certainty and control regarding its litigation costs for current claims and potential future claimants. The proposed class combined with Supreme Court review in their Darnell case are independently necessary and mutually reinforcing steps in the company’s multi-pronged strategy designed to significantly contain the Roundup litigation.”
Bill Anderson, CEO of Bayer said, “the proposed class settlement agreement together with the Supreme Court case provides an essential path out of the litigation uncertainty and enables us to devote our full attention to furthering the innovations that lie at the core of our mission, health for all, hunger for none. This litigation and the resulting cost underscore the need for guidance from the Supreme Court on clear regulation in American agriculture.”
The class settlement and Supreme Court case are both necessary to help bring the strongest, most certain, and most timely containment to this litigation. The total proposed settlement will be $7.25 billion and is subject to court approval with claimants being notified to be able to opt out of the settlement.
Audio Reporting by Dale Sandlin for Southeast AgNet.